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Since the introduction of prevention of mother-to-child-transmission 
(PMTCT) strategies, vertical transmission of HIV has declined in 
low- and middle-income countries over 20 years from 20 - 40% to 
2.8% in the best-case scenarios.1 In wealthy countries, transmission 
rates are below 2%.2,3 In South Africa, the revised clinical guidelines 
introduced in 2010 included starting dual zidovudine/nevirapine 
prophylaxis commencing from 14 weeks’ gestation or lifelong 
antiretroviral treatment (ART) for pregnant women with World 
Health Organization stage III or IV HIV disease and/or CD4 cell 
counts below 350 cells/µl.4 However, improving South African 
PMTCT outcomes has been challenging owing to inadequate coverage 
and sub-optimal implementation of PMTCT programmes.5,6 
Kheth’Impilo (KI) is a non-governmental organisation supporting 
South African Department of Health HIV care facilities. KI provides 
health worker and health system strengthening (including HIV and 
TB integration, infrastructure support and data collection systems). 
Nurse quality mentors (QMs), whose key role is to assist facilities to 
reach the HIV and AIDS National Strategic Plan PMTCT goals, have 
recently been introduced.
To evaluate progress in PMTCT services over an 18-month period 
during which the QM programme was scaled up, PMTCT outcomes 
were analysed at 58 KI-supported primary and secondary level antenatal 
services, across seven high HIV burden sub-districts in three South 
African provinces (KwaZulu-Natal, Mpumalanga and the Eastern Cape).
Methods
QMs are professional nurses experienced in maternal, newborn 
and child health. They focus on quality improvement of PMTCT 
services through a process of mentoring and support of antenatal 
clinic nurses. KI’s QMs support several antenatal care sites within 
a sub-district to improve quality of care, including basic antenatal 
care, family planning, integrated management of childhood illness 
and the Expanded Programme for Immunization. Mentorship 
involves identifying gaps in service delivery, assisting with developing 
solutions, improving patient management, improving patient flow, 
and ensuring that good-quality data are collected. Data registers are 
developed where they do not exist. 
A KI community-support services programme for pregnant 
women and mother-infant pairs linked to health services, comprising 
patient advocates, site facilitators and community co-ordinators, 
provides adherence and psychosocial support. The programme 
encourages early antenatal booking, treatment adherence, HIV 
testing of household members, and HIV DNA polymerase chain 
reaction (PCR) tests for infants 6 weeks after birth, 6 weeks after 
weaning, and at 18 months of age. 
All pregnant women attending antenatal facilities supported by KI 
between October 2009 and March 2011 were included, during which 
time the number of supported sites increased from 14 to 58. Routine 
facility data according to the data elements in the PMTCT register 
were collected and aggregated monthly at facility level, forming part 
of the District Health Information System. Data quality is checked 
by QMs to ensure accuracy, and gaps identified are corrected. Cross-
sectional data from six consecutive quarters were analysed. Primary 
outcomes were positivity rates for PCR tests at 6 weeks of age and 
HIV antibody tests at 18 months of age. Linear trend in outcomes 
was assessed using the Cochrane-Armitage test. Existing electronic 
data from routine monitoring of patients (involving aggregated 
patient counts) were analysed for this report. No procedures were 
performed on patients in addition to those performed routinely. 
Patient-identifying data were not captured electronically.
Results
As the number of KI-supported sites increased during the 
study period, the number of women booking at supported sites 
increased from 5 104 to 9 789 per quarter (Table I). Between Q1 
2010 and Q1 2011, it was evident that increasing proportions of 
women were on ART at booking, rising from 3.6% to 5.4% among 
all women (p<0.0005), and from 30.9% to 37.8% among known 
HIV-positive women (p=0.024). From Q1 2010 onwards, almost 
100% of women with unknown HIV status had an HIV test, up 
from 83% in Q4 2009. A decreasing proportion of HIV-positive 
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women did not know their status at booking (from 72.2% to 
66.1%; p<0.0005), and the proportion of women retested for HIV 
at 32 weeks’ gestation increased from 25.6% to 46.2% (p<0.0005). 
Despite the booking HIV test positivity rate decreasing from 
37.2% to 29.1%, the estimated overall proportion of women who 
were HIV positive at delivery remained around 40% (p=0.74). An 
increasing proportion of newly diagnosed HIV-positive women 
started triple ART (from 16.8% to 21.6%; p<0.0005), due to the 
change in guidelines to initiate triple ART at higher CD4 cell 
counts. 
There was a substantial (75.2%) reduction in early PCR test 
positivity from 9.7% (95% CI 8.1 - 11.5%) to 2.4% (95% CI 1.9 - 
3.1%) over the study period (p<0.0005). The estimated proportion 
of missing PCR results ranged between 0% and 14% per quarter. 
A 64.5% reduction in 18-month HIV test positivity was found, 
declining from 10.7% (95% CI 7.2 - 15.1%) to 3.8% (95% CI 
2.4 - 5.6%) (p<0.0005). The relative proportion of children receiving 
18-month HIV tests versus 6-week PCR tests was low, but improved 
during the last quarter from 19.1% to 24.4%.
Table I. Maternal and infant PMTCT outcomes over six consecutive quarters at facilities supported by Kheth’Impilo
Q4 2009 Q1 2010 Q2 2010 Q3 2010 Q4 2010 Q1 2011 p-trend*
Attended first ANC (N) 5 104 6 445 7 338 6 861 9 098 9 789
Patients known to be HIV positive at 
booking (N (%))
580 (11.4) 752 (11.7) 785 (10.7) 825 (12.0) 1 297 (14.3) 10 406 
(14.4)
<0.0005
Known HIV-positive patients on ART at 
booking (N (%))
211 (36.4) 232 (30.9) 277 (35.3) 281 (34.1) 475 (36.6) 532 (37.8) 0.0238
Proportion ALL patients on ART at booking 
(N (%))
211 (4.1) 232 (3.6) 277 (3.8) 281 (4.1) 475 (5.2) 532 (5.4) <0.0005
Estimated HIV-positive mothers not 
knowing HIV status at booking (N (%))
1 423 (72.2) 2 042 (73.1) 2 168 (75.7) 2 029 (73.6) 2 449 (66.9) 2 559 (66.1) <0.0005
Tested for HIV at booking (N) 3 742 5 817 6 580 6 267 7 722 8 469
Patients not known to be HIV positive, HIV 
tested at booking (%)†
82.7 102 100.4 103.8 99.0 101% <0.0005
Patients HIV tested at booking testing HIV 
positive (N (%))
1 392 (37.2) 2 042 (35.1) 2 080 (31.6) 1 930 (30.8) 2 361 (30.6) 2 468 (29.1) <0.0005
Patients retested at 32 weeks’ gestation (n/N 
(%))‡
801/3 132 
(25.6)
Indicator 
dropped for 
this Q
1 784/4 473 
(39.9)
1 448/4 
106(35.3)
1 987/5 440 
(36.5)
2 734/5 915 
(46.2)
<0.0005
Tested HIV positive at 32 weeks (N (%)) 31 (3.9) - 88 (4.9) 99 (6.8) 88 (4.4) 91 (3.3)
Estimated HIV-positive patients at delivery 
(N (%))
2 003 (39.2) 2 794 (43.4) 2 953 (40.2) 2 854 (41.6) 3 746 (41.2) 3 965 (40.5) 0.74
Provided with CD4 testing (N) 1 582 2 327 2 248 2 123 2 538 2 849
HIV-positive patients (not on ART) provided 
with CD4 test (%)§
88.3 90.8 84 82.5 77.6 83 0.0011
Eligible patients (estimated) received ZDV/
NVP (dual therapy) at delivery (n/N (%))
1 384/1 455 
(95.1) 
2 000/2 194 
(91.2)
2 063/1 943 
(≥100)
2 306/1 993 
(≥100)
2 672/2 454 
(≥100)
2 658/2 576 
(≥100) 
Newly initiated on triple ART (not already 
on ART) at delivery (N)
337 (16.8) 368 (13.2) 733 (24.8) 580 (20.3) 817 (21.8) 857 (21.6) <0.0005
Estimated HIV-positive patients on triple 
ART at delivery (%)
27.3 21.5 34.2 30.1 34.5 35.0 <0.0005¶
Infant details
HIV PCR tests at 6 weeks (N) 1 255 1 706 2 102 2 120 2 480 2 613
Tested HIV positive (PCR) (N (%)) 122 (9.7) 68 (4.0) 83 (3.9) 54 (2.5) 77 (3.1) 63 (2.4) <0.0005
HIV antibody tested (at 18 months, ELISA) (N) 262 343 409 347 474 637
Tested HIV positive (18 months) (N (%)) 28 (10.7) 37 (10.8) 35 (8.6) 29 (8.4) 29 (6.1) 24 (3.8) <0.0005
*Trend tests for proportions were calculated using the Cochrane-Armitage chi-square statistic for trend.
†For trend tests, proportions >100% were calculated as 100%. 
‡Denominator: patients not known to be HIV positive at booking less patients testing HIV positive at booking.
§Denominator: known or newly diagnosed HIV-positive patients not already on ART.
¶p-departure (from linearity of trend) <0.0005.
ANC = antenatal clinic; ART = antiretroviral therapy; ZDV = zidovudine; NVP = nevirapine; PCR = polymerase chain reaction; ELISA = enzyme-linked immunosorbent assay.
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Discussion
PMTCT outcomes improved substantially during a period in which 
new PMTCT guidelines were implemented at sites receiving support 
from nurse QMs and community-based adherence supporters. 
Substantial reductions in early PCR and 18-month HIV test positivity 
rates are encouraging compared with previous outcomes in resource-
limited settings.3,7 The high rates of HIV testing, antiretroviral 
treatment and prophylaxis uptake, and an almost twofold increase 
of the 32-week gestation HIV retest rate, indicate a strengthening 
health system.
The national ART programme demonstrates increased access 
through more women being on triple ART at booking, and increasing 
numbers of pregnant women starting triple ART. This contributes to 
maintaining the high antenatal prevalence of HIV due to increased 
survival of women on ART. The national HIV counselling and testing 
campaign shows greater impact, as more HIV-positive women know 
their status at booking; however, two-thirds still do not know their 
status when booking. 
Many challenges to South African PMTCT programmes 
remain. Pregnant women need to book earlier, and facilities 
should accommodate them without turning them away for later 
appointments. Women may seroconvert during late pregnancy or 
breastfeeding, potentially resulting in vertical transmission. Retesting 
of HIV-negative women through their antenatal phase to the end of 
breastfeeding is required. This may be done through community 
outreach by community care workers and can include testing of 
household members. CD4 cell testing of mothers and early PCR 
testing in infants need to be increased, which may be facilitated by 
point of care CD4 and PCR technology. Longer-term outcomes of 
children are poorly reported in this and other South African studies 
owing to difficulties in follow-up of mothers and children.8 This is 
best addressed through community care workers who understand 
PMTCT and support mothers through their pregnancy to after 
weaning, ensuring regular testing of children at local clinics. Children 
should also receive HIV testing at 18 months regardless of HIV 
exposure history. Mixed feeding is a challenge, as exclusive feeding 
has become stigmatised as an indicator of HIV infection. Exclusive 
breastfeeding should be clearly promoted as the ideal norm for all 
breastfeeding mothers as per government guidelines.
Improved data collection systems for accurate routine reporting, 
and further health systems implementation research, are needed 
as health services strive toward reaching UNAIDS’ vision of zero 
HIV transmission and HIV-related maternal mortality by 2015. To 
achieve this, however, adult HIV prevention efforts with routine HIV 
counselling and testing continue to be imperative.
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